The objective of our pilot study was to determine whether the IL-6 −174G/C polymorphism is a risk factor for the development of adult DM and SLE in Bulgarian patients and to define its contribution to the increased risk. The gene discussed is IL6; the disease is systemic lupus erythematosus.